Nome ME, Euceda LR, Jabeen S, Debik J, et al. Serum levels of inflammation-related markers and metabolites predict response to neoadjuvant chemotherapy with and without bevacizumab in breast cancers. Int J Cancer 2020;146:223-235.
PMID: 31444972